Tumour Antigens
This topic explores the fundamental concepts of tumour antigens, which are critical in understanding cancer immunology at a tertiary level. Tumour antigens are classified into Tumour-Specific Transplantation Antigens (TSTAs) and Tumour-Associated Transplantation Antigens (TATAs), each with distinct origins and immunological implications. TSTAs arise from mutations in proto-oncogenes and tumour suppressor genes, making them unique to cancer cells, while TATAs are often reactivated embryonic proteins or overexpressed normal proteins. For Zambian university and college students pursuing degrees in Biomedical Sciences, Immunology, or related fields, mastering this topic is essential for excelling in examinations and understanding advanced cancer therapies. The content aligns with the University of Zambia's BMS 3325 Immunology syllabus and prepares learners for professional assessments in oncology and immunopathology. Knowledge of tumour antigens is pivotal for grasping how the immune system recognizes cancers and forms the basis for modern immunotherapies, which are increasingly relevant in Zambia's growing healthcare landscape.
How this revision works
- Questions appear in random order
- Feedback after every question
- Retake as often as you like
- Results saved as an exam paper